The Global Clinical Trial Management System (CTMS) Market is on a steep growth trajectory, having been valued at USD 1.80 billion in 2023 and projected to reach USD 5.93 billion by 2032, expanding at a compound annual growth rate (CAGR) of 14.18% during the forecast period of 2024 to 2032. This impressive growth is fueled by the global surge in clinical trials, increasing complexity in trial...